In high-grade serous ovarian cancer, upregulated tRFs can promote protein phosphorylation, transcription, cell migration, cancer pathways, MAPK, and Wnt signaling pathways, as well as regulating HMBOX1 to attack human ovarian cancer cells (Zhang et al., 2019a). This evidence concerns the gene HMBOX1 and ovarian serous adenocarcinoma.